Thomas Stern, MD
Pulmonary Disease · Huntersville, NCNPI 1083639439
Payments from drug & device makers
Across 2,132 payments — averaging $2416.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$1.6M
- Takeda Pharmaceuticals U.S.A., Inc.$729K
- GSK$627K
- Alkermes, Inc.$608K
- Sanofi US Services Inc.$309K
- Harmony Biosciences LLC$238K
- plus $1M from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 926 | $1,594,313 |
| Takeda Pharmaceuticals U.S.A., Inc. | 71 | $728,975 |
| GSK | 176 | $627,344 |
| Alkermes, Inc. | 419 | $608,341 |
| Sanofi US Services Inc. | 31 | $309,170 |
| Harmony Biosciences LLC | 40 | $237,892 |
| AstraZeneca | 39 | $237,324 |
| Avadel CNS Pharmaceuticals, LLC | 53 | $207,121 |
| Chiesi USA, Inc. | 41 | $161,052 |
| Sanofi | 31 | $121,754 |
| Mylan Specialty L.p. | 17 | $115,829 |
| Novartis | 12 | $65,723 |
| Genentech, Inc. | 11 | $57,355 |
| Insmed, Inc. | 188 | $38,339 |
| Pfizer | 3 | $24,715 |
| Verona Pharma, Inc. | 2 | $11,300 |
| Boehringer Ingelheim International GmbH | 30 | $4,162 |
| Inspire Medical Systems, Inc. | 12 | $539 |
| Axsome Therapeutics, Inc. | 3 | $121 |
| Fisher & Paykel Healthcare Inc | 3 | $105 |
| Novo Nordisk | 6 | $103 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Inogen, Inc. | 4 | $67 |
| Boehringer Ingelheim | 3 | $51 |
| Philips North America LLC | 1 | $47 |
| Resmed Corp | 1 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Lundbeck LLC | 1 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$5,151,978 in reported general payments places this provider in the 95th percentile of 393 pulmonary disease providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Huntersville
- Selwyn SpangenthalCharlotte$7M
- Laurie SnyderDurham$3.8M
- Scott PalmerDurham$3.8M
- Michael PritchettPinehurst$2.2M
- Anup BanerjeeGastonia$2.1M
- Hubert FordChapel Hill$2M
- Murali RamaswamyGreensboro$2M
- Mikell JarrattGastonia$1.7M
- Lake MorrisonDurham$1.6M
- Mitchell LeeWilmington$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.